Theratechnologies Statistics
Total Valuation
THTX has a market cap or net worth of $131.16 million. The enterprise value is $179.11 million.
Important Dates
The last earnings date was Wednesday, April 9, 2025, before market open.
| Earnings Date | Apr 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
THTX has 45.98 million shares outstanding. The number of shares has increased by 51.31% in one year.
| Current Share Class | 45.98M |
| Shares Outstanding | 45.98M |
| Shares Change (YoY) | +51.31% |
| Shares Change (QoQ) | +2.10% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 34.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 17.74 |
| PS Ratio | 1.48 |
| Forward PS | 2.07 |
| PB Ratio | -5.36 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.02 |
| EV / EBITDA | 12.17 |
| EV / EBIT | 14.54 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.08
| Current Ratio | 1.08 |
| Quick Ratio | 0.76 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.35 |
| Debt / FCF | n/a |
| Interest Coverage | 1.38 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 11.98% |
| Return on Invested Capital (ROIC) | 25.48% |
| Return on Capital Employed (ROCE) | 57.81% |
| Revenue Per Employee | $860,835 |
| Profits Per Employee | -$36,000 |
| Employee Count | 103 |
| Asset Turnover | 1.38 |
| Inventory Turnover | 2.83 |
Taxes
In the past 12 months, THTX has paid $2.20 million in taxes.
| Income Tax | 2.20M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +119.23% in the last 52 weeks. The beta is 1.50, so THTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | +119.23% |
| 50-Day Moving Average | 1.85 |
| 200-Day Moving Average | 1.53 |
| Relative Strength Index (RSI) | 72.35 |
| Average Volume (20 Days) | 6,276,556 |
Short Selling Information
The latest short interest is 2.03 million, so 4.42% of the outstanding shares have been sold short.
| Short Interest | 2.03M |
| Short Previous Month | 1.19M |
| Short % of Shares Out | 4.42% |
| Short % of Float | 5.81% |
| Short Ratio (days to cover) | 0.25 |
Income Statement
In the last 12 months, THTX had revenue of $88.67 million and -$3.71 million in losses. Loss per share was -$0.08.
| Revenue | 88.67M |
| Gross Profit | 70.02M |
| Operating Income | 12.32M |
| Pretax Income | -6.57M |
| Net Income | -3.71M |
| EBITDA | 14.72M |
| EBIT | 12.32M |
| Loss Per Share | -$0.08 |
Full Income StatementBalance Sheet
The company has $4.34 million in cash and $50.35 million in debt, giving a net cash position of -$46.01 million or -$1.00 per share.
| Cash & Cash Equivalents | 4.34M |
| Total Debt | 50.35M |
| Net Cash | -46.01M |
| Net Cash Per Share | -$1.00 |
| Equity (Book Value) | -24.47M |
| Book Value Per Share | -0.53 |
| Working Capital | 2.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.66 million and capital expenditures -$3,000, giving a free cash flow of -$5.66 million.
| Operating Cash Flow | -5.66M |
| Capital Expenditures | -3,000 |
| Free Cash Flow | -5.66M |
| FCF Per Share | -$0.12 |
Full Cash Flow StatementMargins
Gross margin is 78.97%, with operating and profit margins of 13.89% and -4.18%.
| Gross Margin | 78.97% |
| Operating Margin | 13.89% |
| Pretax Margin | -1.70% |
| Profit Margin | -4.18% |
| EBITDA Margin | 16.60% |
| EBIT Margin | 13.89% |
| FCF Margin | n/a |